FDA Approved: VYLEESI — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Cosette Pharmaceuticals' supplemental application for VYLEESI (bremelanotide), a treatment for hypoactive sexual desire disorder in premenopausal w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Vyleesi (Bremelanotide)

Snippet

SUPPL AP for VYLEESI (BREMELANOTIDE)